Randomized clinical trials towards a single‐visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG‐101 in chronic hepatitis C patients and long‐acting injectable GSK2878175 in healthy participants
Yanli Deng(GlaxoSmithKline (United States)), Martin Leivers(Research Triangle Park Foundation), Ioannis Goulis, Spilios Manolakopoulos(National and Kapodistrian University of Athens), George Papatheodoridis(National and Kapodistrian University of Athens), Tivadar Bányai(Békés Megyei Központi Kórház), Robert Hamatake(Research Triangle Park Foundation), Kelong Han(University of Pittsburgh), Mark A. Deeg(Regulus Therapeutics (United States)), Soumi Lahiri(GlaxoSmithKline (United States)), Gábor Horváth(Buda Health Center), Dickens Theodore, Bernd Jilma(Medical University of Vienna), Shuguang Chen(GlaxoSmithKline (United States)), George Ν. Dalekos(University Hospital of Larissa), Fiona Campbell(University of Birmingham), Michael Huang(Regulus Therapeutics (United States))
Cited by 32
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k
Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials
|Journal of Hypertension|2006|767
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2007|754
Transition of care for adolescents from paediatric services to adult health services
|Cochrane Database of Systematic Reviews|2016|534